Relationships of Executive Functions, Severity of Psychiatric Symptoms With Response to Therapy

Patient Acceptance of Health Care Clinical Trial

Official title:

University of Bojnord

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04603170
• Other study ID #: 13180899
• Status: Completed
• Start date: January 1, 2019
• Est. completion date: March 1, 2019

Study information

• Verified date: October 2020
• Source: University of Bojnord
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study was conducted to investigate the moderating role of executive functions in the relationship between the severity of psychiatric symptoms and response to therapy. The statistical population of this study was all outpatients with anxiety disorders and depression who referred to psychiatric clinics.

Description:

This study was conducted to investigate the moderating role of executive functions in the relationship between the severity of psychiatric symptoms and response to drug therapy in depressed and anxious patients. The statistical population of this study was all outpatients with anxiety disorders and depression who referred to psychiatric clinics. 164 participants completed Outcome Questionnaire, Brief Symptom Inventory, and Behavior Rating Inventory of Executive Function (BRIEF).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 164
• Est. completion date: March 1, 2019
• Est. primary completion date: February 1, 2019
• Gender: All
• Age group: 18 Years to 60 Years

Eligibility

Inclusion Criteria:

receiving a diagnosis of anxiety and depression disorders, age over 18 years, and taking drug medication prescribed by psychiatrists for at least one month.-

Exclusion Criteria:

• having psychotic disorders, age under 18 years and absence from treatment.

Related Conditions & MeSH terms

• Patient Acceptance of Health Care

Intervention

Other:
• DRUG
taking drug medication prescribed by psychiatrists for at least one month

Locations

Country	Name	City	State
Iran, Islamic Republic of	Malahat Amani	Bojnourd	North Khorsan

Sponsors (1)

Lead Sponsor	Collaborator
Malahat Amani

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Outcome questionnaire	This questionnaire was designed to assess response to treatment. This questionnaire has the dimension of mental distress or signs of distress, interpersonal relationships, and social role. This 45-item questionnaire is answered on a 5-point Likert scale ranging 0 to 4 (not at all to extremely).Scores range from 0 to180. higher scores mean a worse outcome.	ONE WEEK
Primary	Brief Symptom Inventory	This inventory measures the symptoms of psycho-somatization, obsessive-compulsive, interpersonal sensitivity, paranoid thoughts, depression, psychosis, general anxiety, hostility and anxiety. It was answered to questions based on the 5-point Likert scale ranging from 0 to 4 (not at all to perfectly). This questionnaire is 53 items. Scores range from 0 to 212.range of score are higher scores mean a worse outcome and mental health problems.	ONE WEEK
Primary	Behavior Rating Inventory of Executive Function	This questionnaire is used to measure the executive functions of adults aged 18 to 90 from their daily performance in the natural environment. It has 75 items that measure factors including response inhibition, shifting, emotional control, self-monitoring, initiation, working memory, planning, material organization, and task monitoring. It was answered to questions based on the 3-point Likert scale ranging from 0 to 2 (not at all to extremely). the scores range 0 to 150. High score is indicator of weak executive functions.	ONE WEEK